This article is a stub. Please feel free to expand it and make it more encyclopaedic.
Quadrivalent vaccine against Human Papillomavirus infection. This vaccine protects against types 6 & 11 (the types causing 90+% of cases of genital warts in an unprotected population) and 16 & 18 (the main oncogenic types, which cause 70+% of cases of cervical cancer, and 90+% of cases of anal cancer in an unprotected population).
Manufactured in Europe by Sanofi Pasteur MSD.